{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:40:34Z","timestamp":1760575234059,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ejps.2020.105409","type":"journal-article","created":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T02:17:36Z","timestamp":1591409856000},"page":"105409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Species differences in the drug\u2013drug interaction between atorvastatin and cyclosporine: In vivo study using a stable isotope-IV method in rats and dogs"],"prefix":"10.1016","volume":"152","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4867-9361","authenticated-orcid":false,"given":"Keiko","family":"Minami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruki","family":"Higashino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejps.2020.105409_bib0001","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1124\/mol.118.112912","article-title":"Functional expression of organic anion transporting polypeptide 1a4 is regulated by transforming growth factor-\u03b2\/activin receptor-like kinase 1 signaling at the blood-brain barrier","volume":"94","author":"Abdullahi","year":"2018","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejps.2020.105409_bib0002","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1034\/j.1600-6143.2001.10415.x","article-title":"Bilateral pharmacokinetic interaction between cyclosporine A and atorvastatin in renal transplant recipients","volume":"1","author":"Asberg","year":"2001","journal-title":"Am. J. Transplant."},{"issue":"2","key":"10.1016\/j.ejps.2020.105409_bib0003","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1006\/bbrc.1993.2487","article-title":"Evidence for a polarized efflux system in CACO-2 cells capable of modulating cyclosporin A transport","volume":"197","author":"Augustijns","year":"1993","journal-title":"Biochem. Biophys. Res. Commun"},{"issue":"8","key":"10.1016\/j.ejps.2020.105409_bib0004","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0090-9556(24)15242-7","article-title":"Metabolism and excretion of atorvastatin in rats and dogs","volume":"27","author":"Black","year":"1999","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.ejps.2020.105409_bib0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12987-018-0110-9","article-title":"Sex-specific differences in organic anion transporting polypeptide 1a4 (Oatp1a4) functional expression at the blood-brain barrier in Sprague-Dawley rats","volume":"15","author":"Brzica","year":"2018","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.ejps.2020.105409_bib0006","first-page":"S253","volume":"14","author":"Gibson","year":"1997","journal-title":"Absolute bioavailability of atorvastatin in man"},{"issue":"1","key":"10.1016\/j.ejps.2020.105409_bib0007","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.clpt.2003.09.011","article-title":"Pharmacokinetics and pharmacodynamics of pravastatin in pediatric and adolescent cardiac transplant recipients on a regimen of triple immunosuppression","volume":"75","author":"Hedman","year":"2004","journal-title":"Clin. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.ejps.2020.105409_bib0008","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.clpt.2004.07.008","article-title":"Substantially elevated levels of atorvastatin and metabolites in cyclosporine-treated renal transplant recipients","volume":"76","author":"Hermann","year":"2004","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2020.105409_bib0009","first-page":"37","article-title":"The incremental effect and mechanism of cyclosporine on blood concentration of statins and statin package insert information in Japan","volume":"123","author":"Hirata-Koizumi","year":"2005","journal-title":"Bull. Natl. Inst. Health Sci."},{"issue":"52","key":"10.1016\/j.ejps.2020.105409_bib0010","doi-asserted-by":"crossref","first-page":"37161","DOI":"10.1074\/jbc.274.52.37161","article-title":"A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters","volume":"274","author":"Hsiang","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ejps.2020.105409_bib0011","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1248\/bpb.28.316","article-title":"In vivo effects of cyclosporin A and ketoconazole on the pharmacokinetics of representative substrates for P-glycoprotein and cytochrome P450 (CYP) 3A in rats","volume":"28","author":"Kageyama","year":"2005","journal-title":"Biol. Pharm. Bull."},{"issue":"7","key":"10.1016\/j.ejps.2020.105409_bib0012","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/01.fpc.0000170913.73780.5f","article-title":"Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells","volume":"15","author":"Kameyama","year":"2005","journal-title":"Pharmacogenet Genom."},{"issue":"6","key":"10.1016\/j.ejps.2020.105409_bib0013","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.dmpk.2016.08.001","article-title":"Quantitative analysis of pharmacokinetic profiles of verapamil and drug-drug interactions induced by a CYP inhibitor using a stable isotope-labeled compound","volume":"31","author":"Kataoka","year":"2016","journal-title":"Drug Metab. Pharmacokinet"},{"issue":"3 Suppl","key":"10.1016\/j.ejps.2020.105409_bib0014","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.jacl.2014.02.010","article-title":". The national lipid association's safety task force. A clinician's guide to statin drug-drug interactions","volume":"8","author":"Kellick","year":"2014","journal-title":"J. Clin. Lipidol."},{"issue":"1","key":"10.1016\/j.ejps.2020.105409_bib0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2133\/dmpk.24.37","article-title":"In vitro-in vivo extrapolation of transporter-mediated clearance in the liver and kidney","volume":"24","author":"Kusuhara","year":"2009","journal-title":"Drug Metab. Pharmacokinet"},{"issue":"7","key":"10.1016\/j.ejps.2020.105409_bib0016","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1124\/dmd.111.038075","article-title":"Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs","volume":"39","author":"Li","year":"2011","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.ejps.2020.105409_bib0017","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/clpt.2011.142","article-title":"Identification of the rate-determining process in the hepatic clearance of atorvastatin in a clinical cassette microdosing study","volume":"90","author":"Maeda","year":"2011","journal-title":"Clin. Pharmacol. Ther"},{"issue":"8","key":"10.1016\/j.ejps.2020.105409_bib0018","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1016\/j.xphs.2019.03.023","article-title":"Analysis of the complicated nonlinear pharmacokinetics of orally administered telmisartan in rats using a stable isotope-IV method","volume":"108","author":"Minami","year":"2019","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ejps.2020.105409_bib0019","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0009-9236(99)70104-9","article-title":"Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients","volume":"65","author":"M\u00fcck","year":"1999","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.ejps.2020.105409_bib0020","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0022-3565(24)29609-9","article-title":"Human liver-specific organic anion transporter, LST-1, mediates uptake of pravastatin by human hepatocytes","volume":"297","author":"Nakai","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.ejps.2020.105409_bib0021","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1254\/fpj.133.337","article-title":"In vivo evaluation of drug absorption in the discovery stage]","volume":"133","author":"Nakai","year":"2009","journal-title":"Nihon Yakurigaku Zasshi"},{"issue":"4","key":"10.1016\/j.ejps.2020.105409_bib0022","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/107424840100600404","article-title":"Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A","volume":"6","author":"Park","year":"2001","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.ejps.2020.105409_bib0023","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.clpt.2004.03.010","article-title":"Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine","volume":"76","author":"Simonson","year":"2004","journal-title":"Clin. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.ejps.2020.105409_bib0024","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/j.1552-4604.1997.tb05629.x","article-title":"Renal dysfunction does not alter the pharmacokinetics or LDL-cholesterol reduction of atorvastatin","volume":"37","author":"Stern","year":"1997","journal-title":"J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejps.2020.105409_bib0025","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2133\/dmpk.14.286","article-title":"Moment analysis program available on Microsoft Excel\u00ae","volume":"14","author":"Tabata","year":"1999","journal-title":"Drug Metab. Pharmacokinet"},{"issue":"4","key":"10.1016\/j.ejps.2020.105409_bib0026","doi-asserted-by":"crossref","first-page":"510","DOI":"10.18433\/J3F602","article-title":"Regional differences in the components of luminal water from rat gastrointestinal tract and comparison with other species","volume":"15","author":"Tanaka","year":"2012","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ejps.2020.105409_bib0027","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1124\/dmd.114.061580","article-title":"Interspecies variability in expression of hepatobiliary transporters across human, dog, monkey, and rat as determined by quantitative proteomics","volume":"43","author":"Wang","year":"2015","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.ejps.2020.105409_bib0028","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1124\/dmd.109.030254","article-title":"Investigation of the rate-determining process in the hepatic elimination of HMG-CoA reductase inhibitors in rats and humans","volume":"38","author":"Watanabe","year":"2010","journal-title":"Drug Metab. Dispos."},{"issue":"5","key":"10.1016\/j.ejps.2020.105409_bib0029","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2165\/00003088-200241050-00003","article-title":"Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors","volume":"41","author":"Williams","year":"2002","journal-title":"Clin. Pharmacokinet"},{"issue":"9","key":"10.1016\/j.ejps.2020.105409_bib0030","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1016\/j.xphs.2017.04.027","article-title":"Quantitative Analysis of the transporter-mediated drug-drug interaction between atorvastatin and rifampicin using a stable isotope-IV method","volume":"106","author":"Yamashita","year":"2017","journal-title":"J. Pharm. Sci."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720301986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720301986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:52:49Z","timestamp":1760529169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098720301986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":30,"alternative-id":["S0928098720301986"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105409","relation":{},"ISSN":["0928-0987"],"issn-type":[{"type":"print","value":"0928-0987"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Species differences in the drug\u2013drug interaction between atorvastatin and cyclosporine: In vivo study using a stable isotope-IV method in rats and dogs","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105409"}}